Related Experiment Videos

[Endocardial fibroelastosis in children to one year of age]

M Sobaniec-Zotowska1, S Sulkowski, W Sobaniec

  • 1Zakładu Anatomii Patologicznej AM, Białymstoku.

Polski Tygodnik Lekarski (Warsaw, Poland : 1960)
|February 4, 1991
PubMed

Insights

Endocardial fibroelastosis (EFE) affected 10.6% of congenital heart disease cases in infants. This study highlights EFE

Area of Science:

  • Pediatric Pathology
  • Cardiovascular Diseases
  • Congenital Abnormalities

Context:

  • Endocardial fibroelastosis (EFE) is a rare congenital heart disease.
  • Autopsy data from 2398 newborns and infants (1976-1985) were analyzed.
  • EFE represented 10.6% of congenital heart diseases in this cohort.

Purpose:

  • To investigate the incidence, characteristics, and potential etiopathogenesis of endocardial fibroelastosis in infants.
  • To analyze morphological features and associated conditions of EFE.
  • To assess the clinical diagnostic accuracy of EFE.

Summary:

  • Thirty-two cases of EFE were identified, most frequent in infants aged 3-6 months.
  • EFE occurred in both male and female infants, with 62.5% being primary and 37.5% secondary.
  • Associated conditions included joint, bone, and respiratory abnormalities. Etiopathogenesis may involve congenital factors, myocardial infection, or collagenic disease. The disease course was severe, with low clinical diagnostic rates (18.75%).

Impact:

  • Provides crucial data on EFE prevalence and associations in an infant autopsy cohort.
  • Suggests potential etiological pathways, including congenital origin, infection, and collagenic disease.
  • Underscores the diagnostic challenges and severity of EFE in infants.

Related Concept Videos